Skip to main content

Table 1 Clinical characteristics of the enrolled patients

From: The experience of high-flow nasal cannula in hospitalized patients with 2019 novel coronavirus-infected pneumonia in two hospitals of Chongqing, China

 Total cohort
N = 17
Age, years65 (56–75)
Male (%)7 (41%)
APACHE II score8 (5–11)
SOFA score3.0 (2.5–3.5)
Duration of HFNC, hours76 (34–186)
Comorbidity
 Hypertension3 (18%)
 Diabetes mellitus3 (18%)
 Chronic heart disease3 (18%)
Laboratory tests
 White blood cell counts, × 109/L5.4 (4.2–7.1)
 Lymphocyte count, × 109/L0.7 (0.5–0.9)
 Platelet counts, × 109/L154 (121–259)
 Hemoglobin, mg/dL128 (118–138)
 Albumin, g/L35 (32–38)
 Potassium, mmol/L3.9 (3.5–4.2)
 Sodium, mmol/L136 (135–138)
 Chlorine, mmol/L101 (99–105)
 Creatinine, μmol/L60 (53–69)
 Total bilirubin, μmol/L11 (10–15)
 C-reactive protein, mg/L39 (22–67)
 Procalcitonin, ng/mL0.07 (0.06–0.09)
  1. APACHE II acute physiology and chronic health evaluation II, SOFA sequential organ failure assessment